Sponsor pulls Sublocade from PBS

Manufacturer makes “commercial decision to discontinue supply” of one of two PBS-listed long-acting injectable buprenorphine products  Sublocade is the latest in the growing list of medications being withdrawn from the Pharmaceutical Benefits Scheme (PBS) in 2026.  The sponsor of the long-acting injectable buprenorphine drug, Indivior announced that it will cease supply of the treatment to